PDE9A and hydrops fetalis: Whether another cGMP‐selective phosphodiesterase, PDE9A, is more highly expressed in failing human cardiomyocytes, is a controversial issue requiring further study 127, 128, as do the potential benefits of inhibiting PDE9A on titin phosphorylation and LV passive stiffness in human HF.